Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MAVS as a Key Regulator of Tumor Proliferation, Survival, the Tumor Microenvironment, and Immunity.

Biomolecules·2026
Same author

Disrupting VDAC1-tubulin interaction uncovers crosstalk between mitochondrial and microtubule functions with implication to cancer therapy.

Cellular and molecular life sciences : CMLS·2026
Same author

p53 Interacts with VDAC1, Modulating Its Expression Level and Oligomeric State to Activate Apoptosis.

Biomolecules·2026
Same author

Resveratrol's Pro-Apoptotic Effects in Cancer Are Mediated Through the Interaction and Oligomerization of the Mitochondrial VDAC1.

International journal of molecular sciences·2025
Same author

Correction to: Elevated serum mtDNA in COVID‑19 patients is linked to SARS‑CoV‑2 envelope protein targeting mitochondrial VDAC1, inducing apoptosis and mtDNA release.

Apoptosis : an international journal on programmed cell death·2025
Same author

Annexin A5 controls VDAC1-dependent mitochondrial Ca<sup>2+</sup> homeostasis and determines cellular susceptibility to apoptosis.

The EMBO journal·2025

Related Experiment Video

Updated: Jun 9, 2025

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

20.5K

Decoding Cancer through Silencing the Mitochondrial Gatekeeper VDAC1.

Tasleem Arif1,2, Anna Shteinfer-Kuzmine3, Varda Shoshan-Barmatz3,4

  • 1Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.

Biomolecules
|October 26, 2024
PubMed
Summary
This summary is machine-generated.

Silencing voltage-dependent anion channel 1 (VDAC1) reverses cancer

Keywords:
VDAC1metabolismmitochondriasiRNAstem cells

More Related Videos

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.0K
Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples
09:57

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples

Published on: May 10, 2017

7.6K

Related Experiment Videos

Last Updated: Jun 9, 2025

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

20.5K
Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.0K
Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples
09:57

Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples

Published on: May 10, 2017

7.6K

Area of Science:

  • Mitochondrial biology
  • Cancer cell metabolism
  • Epigenetics

Background:

  • Mitochondria regulate key cellular processes including metabolism and apoptosis.
  • Voltage-dependent anion channel 1 (VDAC1) is a mitochondrial gatekeeper controlling ion and metabolite transport.
  • VDAC1 is overexpressed in many cancers and linked to the Warburg effect.

Purpose of the Study:

  • To investigate the therapeutic potential of targeting VDAC1 in cancer.
  • To explore the effects of VDAC1 silencing on cancer cell phenotype and the tumor microenvironment.

Main Methods:

  • Silencing VDAC1 expression using small interfering RNA (siRNA) in various tumor types.
  • Analysis of metabolic rewiring, oncogenic properties, tumor growth, invasiveness, stemness, and epithelial-mesenchymal transition.
  • Assessment of changes in the tumor microenvironment, angiogenesis, and extracellular matrix gene expression.
  • Evaluation of VDAC1 depletion effects on epigenetic enzymes and histone modifications.

Main Results:

  • VDAC1 silencing reversed cancer cell metabolic reprogramming and oncogenic properties.
  • Reduced tumor growth, invasiveness, and stemness were observed.
  • VDAC1 depletion altered the tumor microenvironment, reducing angiogenesis.
  • Epigenetic modifications, including histone acetylation and methylation changes, were induced, affecting gene expression.

Conclusions:

  • Targeting VDAC1 is a promising anti-cancer therapeutic strategy, particularly for high-energy-demand cancers.
  • VDAC1 silencing offers a novel approach to combat cancer by modulating metabolism and epigenetics.
  • VDAC1's role extends to other pathologies, suggesting broader therapeutic potential.